VitaNova Life Sciences (VNOV) Profit After Tax Growth (1y) (2018 - 2026)
VitaNova Life Sciences (VNOV) Profit After Tax Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 24.19% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 12.60% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 63.79% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 8.51% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -126.15% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 89.75% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -286.67% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -117.16% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -97.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -97.81% |
| Jan 31, 2026 | -160.79% |
| Oct 31, 2025 | 9.69% |
| Jul 31, 2025 | 16.14% |
| Apr 30, 2025 | 376.62% |
| Jan 31, 2025 | 1,126.93% |
| Oct 31, 2024 | 472.90% |
| Jul 31, 2024 | -127.70% |
| Apr 30, 2024 | 3,929.40% |
| Jan 31, 2024 | 124.20% |
| Oct 31, 2023 | -436.60% |
| Jul 31, 2023 | -1,236.22% |
| Apr 30, 2023 | 83.64% |
| Jan 31, 2023 | -375.62% |
| Oct 31, 2022 | -82.67% |
| Jul 31, 2022 | -98.50% |
| Apr 30, 2022 | -4.87% |
| Jan 31, 2022 | 407.59% |
| Oct 31, 2021 | 221.19% |
| Jul 31, 2021 | 1,367.56% |